{"entity":{"type":"insider","cik":"0001789673","url":"/insider/0001789673","json_url":"/insider/0001789673.json","name":"Lehrer-Graiwer Joshua","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":9,"first":"2019-11-18","last":"2020-03-09","span_basis":"filed_date"},"name_variants":[{"name":"Lehrer-Graiwer Joshua","source":"filing","n_filings":9,"first_seen":"2019-11-18","last_seen":"2020-03-09"}],"transactions":[{"id":2281957,"accession":"0000899243-20-007676","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-007676","line_url":"/filing/0000899243-20-007676#line-3","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":938.0,"shares_display":"938","price_per_share":59.9,"price_display":"59.90","price_state":"stated","total_value":56186.2,"total_display":"56,186.20","total_whole":"56,186","shares_owned_after":2595.0,"shares_owned_after_display":"2,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-09","scope":"insider"},{"id":2281939,"accession":"0000899243-20-007676","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-007676","line_url":"/filing/0000899243-20-007676#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1138.0,"shares_display":"1,138","price_per_share":65.3,"price_display":"65.30","price_state":"stated","total_value":74311.4,"total_display":"74,311.40","total_whole":"74,311","shares_owned_after":2595.0,"shares_owned_after_display":"2,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-05","filed_date":"2020-03-09","scope":"insider"},{"id":2952334,"accession":"0000899243-20-005350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005350","line_url":"/filing/0000899243-20-005350#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1313.0,"shares_display":"1,313","price_per_share":69.71,"price_display":"69.71","price_state":"stated","total_value":91529.23,"total_display":"91,529.23","total_whole":"91,529","shares_owned_after":2595.0,"shares_owned_after_display":"2,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider"},{"id":2506353,"accession":"0000899243-20-003859","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-003859","line_url":"/filing/0000899243-20-003859#line-3","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":70.48,"price_display":"70.48","price_state":"stated","total_value":44050.0,"total_display":"44,050.00","total_whole":"44,050","shares_owned_after":2595.0,"shares_owned_after_display":"2,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-10","scope":"insider"},{"id":2506342,"accession":"0000899243-20-003859","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-003859","line_url":"/filing/0000899243-20-003859#line-1","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3937.0,"shares_display":"3,937","price_per_share":72.4,"price_display":"72.40","price_state":"stated","total_value":285038.8,"total_display":"285,038.80","total_whole":"285,039","shares_owned_after":2595.0,"shares_owned_after_display":"2,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-10","scope":"insider"},{"id":2039438,"accession":"0000899243-20-003032","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-003032","line_url":"/filing/0000899243-20-003032","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3845.0,"shares_display":"3,845","price_per_share":63.7537789336801,"price_display":"63.75","price_state":"stated","total_value":245133.28,"total_display":"245,133.28","total_whole":"245,133","shares_owned_after":6532.0,"shares_owned_after_display":"6,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider","n_lines":2},{"id":2540913,"accession":"0000899243-20-002292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-002292","line_url":"/filing/0000899243-20-002292#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":71.15,"price_display":"71.15","price_state":"stated","total_value":55568.15,"total_display":"55,568.15","total_whole":"55,568","shares_owned_after":2016.0,"shares_owned_after_display":"2,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-29","scope":"insider"},{"id":8091961,"accession":"0000899243-19-028940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028940","line_url":"/filing/0000899243-19-028940#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":937.0,"shares_display":"937","price_per_share":78.5,"price_display":"78.50","price_state":"stated","total_value":73554.5,"total_display":"73,554.50","total_whole":"73,555","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7910097,"accession":"0000899243-19-028243","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000899243-19-028243","line_url":"/filing/0000899243-19-028243#line-16","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11593.0,"shares_display":"11,593","price_per_share":67.19,"price_display":"67.19","price_state":"stated","total_value":778933.67,"total_display":"778,933.67","total_whole":"778,934","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-27","scope":"insider"},{"id":7910091,"accession":"0000899243-19-028243","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-19-028243","line_url":"/filing/0000899243-19-028243","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10930.0,"shares_display":"10,930","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":655800.0,"total_display":"655,800.00","total_whole":"655,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-27","scope":"insider","n_lines":7},{"id":8611619,"accession":"0000899243-19-027721","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-027721","line_url":"/filing/0000899243-19-027721#line-4","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6562.0,"shares_display":"6,562","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":360910.0,"total_display":"360,910.00","total_whole":"360,910","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-20","scope":"insider"},{"id":8611614,"accession":"0000899243-19-027721","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027721","line_url":"/filing/0000899243-19-027721#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":656.0,"shares_display":"656","price_per_share":50.63,"price_display":"50.63","price_state":"stated","total_value":33213.28,"total_display":"33,213.28","total_whole":"33,213","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":7886776,"accession":"0000899243-19-027545","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-19-027545","line_url":"/filing/0000899243-19-027545#line-9","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9948.0,"shares_display":"9,948","price_per_share":50.0047,"price_display":"50.00","price_state":"stated","total_value":497446.7556,"total_display":"497,446.76","total_whole":"497,447","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-18","scope":"insider"},{"id":7886753,"accession":"0000899243-19-027545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027545","line_url":"/filing/0000899243-19-027545#line-2","is_derivative":false,"issuer_cik":"0001629137","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001629137","owner_cik":"0001789673","owner_name":"Lehrer-Graiwer Joshua","owner_display_name":"Lehrer-Graiwer Joshua","owner_url":"/insider/0001789673","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329.0,"shares_display":"329","price_per_share":50.0137,"price_display":"50.01","price_state":"stated","total_value":16454.5073,"total_display":"16,454.51","total_whole":"16,455","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Officer (Chief Medical Officer)","n_filings":9,"first_seen":"2019-11-18","last_seen":"2020-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001789673","retrieved_at":"2026-08-22T12:39:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}